Table 2

Safety and effectiveness outcomes among study patients in fiscal years 2008 and 2010 according to improvement in ED length of stay

Improved sitesNon-improved sites
2008201020082010
Safety/effectiveness outcomeNn (%)Nn (%)Nn (%)Nn (%)
AMI reperfusion—eligible patients166119 (71.7)10362 (60.2)203107 (52.7)15976 (47.8)
AMI reperfusion—eligible STEMIs129112 (86.8)6757 (85.1)10898 (90.7)7268 (94.4)
AMI ASA652547 (83.9)642522 (81.3)676522 (77.2)676548 (81.1)
Asthma lung function test682172 (25.2)669165 (24.7)689145 (21.0)689147 (21.3)
Asthma no chest X-ray682413 (60.6)669379 (56.7)689368 (53.4)689355 (51.5)
Asthma corticosteroid prescription documented682472 (69.2)669432 (64.6)689388 (56.3)689395 (57.3)
Asthma discharge instructions documented682531 (77.9)669533 (79.7)689469 (68.1)689502 (72.9)
Adult fracture pain assessment504257 (51.0)506253 (50.0)507264 (52.1)507268 (52.9)
Adult fracture analgesic or splinting504463 (91.9)506464 (91.7)507468 (92.3)507477 (94.1)
Adult fracture discharge instructions documented504447 (88.7)506453 (89.5)507437 (86.2)507431 (85.0)
Paediatric fracture pain assessment336137 (40.8)328157 (47.9)377157 (41.6)377172 (45.6)
Paediatric fracture analgesic or splinting336303 (90.2)328307 (93.6)377335 (88.9)377342 (90.7)
Paediatric fracture discharge instructions documented336304 (90.5)328311 (94.8)377333 (88.3)377341 (90.5)
  • AMI, acute myocardial infarction; ASA, acetylsalicylic acid; ED, emergency department; STEMI, ST-elevated myocardial infarction.